• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dataset reporting detection of breast cancer-related polymorphism using allele-specific polymerase chain reaction.

作者信息

Budiarto Bugi Ratno

机构信息

Research Center for Biotechnology, Indonesian Institute of Sciences (LIPI), Jalan Raya Bogor Km. 46, Cibinong 16911, Indonesia.

出版信息

Data Brief. 2016 Sep 24;9:689-695. doi: 10.1016/j.dib.2016.09.033. eCollection 2016 Dec.

DOI:10.1016/j.dib.2016.09.033
PMID:27790634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5072141/
Abstract

The dataset presented in this article is related to the research article entitled "Detection of Gene Polymorphism in Breast Cancer: PCR Optimization Study" (B.R. Budiarto, Desriani, 2016) [1] with some modification in primers used and in PCR optimization strategy to eliminate false-positive result that may occur in polymorphism detection. Combining a new set of primers with PCR gradient, The allele-specific PCR well performs to detect all type of breast cancer-originated genotypes. The validation of this method was done using Sanger DNA sequencing, offering an alternative tool for polymorphism detection in another type of cancer.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/11ed4dd063cd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/25bd1a49af92/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/8f0afc4f7467/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/bc420c6304c1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/11ed4dd063cd/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/25bd1a49af92/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/8f0afc4f7467/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/bc420c6304c1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0872/5072141/11ed4dd063cd/gr4.jpg

相似文献

1
Dataset reporting detection of breast cancer-related polymorphism using allele-specific polymerase chain reaction.
Data Brief. 2016 Sep 24;9:689-695. doi: 10.1016/j.dib.2016.09.033. eCollection 2016 Dec.
2
The HER2 I655V polymorphism and breast cancer risk in Ashkenazim.阿什肯纳兹人群中HER2 I655V基因多态性与乳腺癌风险
Epidemiology. 2003 Nov;14(6):694-700. doi: 10.1097/01.ede.0000083227.74669.7b.
3
Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.乳腺癌中HER2基因多态性的检测:聚合酶链反应优化研究
Sci Pharm. 2016 Feb 14;84(1):103-11. doi: 10.3797/scipharm.ISP.2015.03. Print 2016 Jan-Mar.
4
BCL-2 (-938C>A), BAX (-248G>A), and HER2 Ile655Val Polymorphisms and Breast Cancer Risk in Indian Population.BCL-2(-938C>A)、BAX(-248G>A)和HER2 Ile655Val多态性与印度人群乳腺癌风险
J Oncol. 2021 Feb 25;2021:8865624. doi: 10.1155/2021/8865624. eCollection 2021.
5
Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.HER2 外显子 655 位 Ile655Val 多态性与可手术原发性乳腺癌女性对曲妥珠单抗反应的相关性。
Ann Oncol. 2014 Jun;25(6):1158-64. doi: 10.1093/annonc/mdu111. Epub 2014 Mar 7.
6
Correction: Budiarto, Bugi Ratno and Desriani. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study. Sci. Pharm. 2016, 84, 103-111.更正:布迪阿托、布吉·拉特诺和德斯里亚尼。乳腺癌中HER2基因多态性的检测:PCR优化研究。《科学制药》2016年,第84卷,第103 - 111页。
Sci Pharm. 2016 Dec 2;84(4):753. doi: 10.3390/scipharm84040753.
7
The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.HER2基因I655V多态性与40岁以下女性患乳腺癌的风险
Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1109-11.
8
ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.ABCB1 C3435T 基因多态性作为 HER2 阳性乳腺癌患者临床结局的潜在生物标志物。
Pharmacol Res. 2016 Jun;108:111-118. doi: 10.1016/j.phrs.2016.04.016. Epub 2016 Apr 30.
9
HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer.卵巢癌患者中HER2基因第655位密码子异亮氨酸突变为缬氨酸的单核苷酸多态性
Iran Red Crescent Med J. 2013 Jan;15(1):1-3. doi: 10.5812/ircmj.2173. Epub 2013 Jan 5.
10
Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.HER2 I655V 多态性与乳腺癌风险之间关联的缺乏复制:系统评价和荟萃分析。
Cancer Epidemiol. 2011 Dec;35(6):503-9. doi: 10.1016/j.canep.2011.01.007. Epub 2011 Apr 7.

引用本文的文献

1
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.非小细胞肺癌中的新型新兴分子靶点。
Int J Mol Sci. 2021 Mar 5;22(5):2625. doi: 10.3390/ijms22052625.

本文引用的文献

1
Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.乳腺癌中HER2基因多态性的检测:聚合酶链反应优化研究
Sci Pharm. 2016 Feb 14;84(1):103-11. doi: 10.3797/scipharm.ISP.2015.03. Print 2016 Jan-Mar.
2
HER2 polymorphisms and breast cancer in Tunisian women.突尼斯女性中的人表皮生长因子受体2(HER2)基因多态性与乳腺癌
Genet Test Mol Biomarkers. 2010 Feb;14(1):29-35. doi: 10.1089/gtmb.2009.0069.
3
Allele-specific PCR in SNP genotyping.单核苷酸多态性(SNP)基因分型中的等位基因特异性PCR
Methods Mol Biol. 2009;578:415-24. doi: 10.1007/978-1-60327-411-1_26.
4
HER-2/neu Ile655Val polymorphism and the risk of breast cancer.HER-2/neu基因Ile655Val多态性与乳腺癌风险
Ann N Y Acad Sci. 2008 Sep;1138:84-94. doi: 10.1196/annals.1414.014.
5
Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.人表皮生长因子受体2(HER2)基因Ile655Val多态性和细胞周期蛋白D1(CCND1)基因G870A多态性与乳腺癌风险无关,但HER2基因的多态性等位基因与淋巴结转移有关。
Neoplasma. 2008;55(2):87-95.
6
A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.一项关于HER2基因Ile655Val多态性与浸润性乳腺癌风险关系的病例对照研究。
Breast Cancer Res. 2005;7(3):R357-64. doi: 10.1186/bcr1004. Epub 2005 Mar 11.
7
Her2 genotype and breast cancer progression in Korean women.韩国女性的Her2基因分型与乳腺癌进展
Pathol Int. 2005 Feb;55(2):48-52. doi: 10.1111/j.1440-1827.2005.01789.x.
8
HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites.HER2基因第655位密码子多态性与非裔美国人和白人患乳腺癌的风险
Breast Cancer Res Treat. 2003 Jun;79(3):355-64. doi: 10.1023/a:1024068525763.
9
Distribution of HER2(V655) genotypes in breast cancer cases and controls in the United States.
Cancer Lett. 2001 Nov 8;173(1):37-41. doi: 10.1016/s0304-3835(01)00671-1.
10
Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.基于人群的HER2基因多态性与乳腺癌风险的病例对照研究。
J Natl Cancer Inst. 2000 Mar 1;92(5):412-7. doi: 10.1093/jnci/92.5.412.